2025 American Society of Clinical Oncology Annual Meeting
The 2025 American Society of Clinical Oncology Annual Meeting will feature key research and treatment updates for nurses and advanced practitioners in oncology. The annual meeting provides opportunities to “discover state-of-the-art research, groundbreaking treatments, and visionary insights that will ignite your passion for oncology,” organizers said. The meeting is taking place May 30 to June 2, 2025, in Chicago, Illinois.
Palliative care researchers discuss breast cancer palliative care disparities among Hispanic subgroups.
Patients with ccRCC were randomly selected to receive pembrolizumab or placebo and categorized by risk for metastasis.
The study evaluated the effect of pretreatment emotional distress on OS among more than 3,000 patients with solid tumors.
After the NuGenA program was implemented, the team of researchers extended their outreach to South Asia and South Africa.
APP-First was created to assist in testing completion and referrals before a new patient meets with a surgical oncologist.
Because it is used to detect kidney injuries, researchers evaluated KIM-1 as a liquid-based biomarker in patients with RCC.
The researchers compared the combination therapy with the current standard of care to explore impact on overall survival.
The ODYSSEY trial is comparing quality of life with combination IO treatments in real-world settings versus clinical trials.
Learn more about how disparities among patients with metastatic renal cancer have influenced mortality rates.
Researchers explored patterns and associated factors related to hospice use in patients with a variety of advanced cancers.
Palliative care researchers discuss why it's critical to bring together interdisciplinary voices at the annual meeting.
The study explored whether existing racial and socioeconomic disparities affect the overall survival of patients with mRCC.
Researchers evaluated whether TKIs increase the risk of hernias or hernia complications due to their impact on wound healing.
Advertisement